Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Update on Plans

17 Jul 2007 07:01

Quadrise Fuels International PLC17 July 2007 17th July 2007 Quadrise Fuels International plc ("Quadrise" or "the Company") AIM: QFI QUADRISE FUELS INTERNATIONAL IDENTIFIES OIL REFINING INDUSTRY AS MAJOR AREA FOR GROWTH Quadrise Fuels International, the AIM listed specialist manufacturer of MSAR(R)emulsion, plans to target the oil refining industry to promote its technologywhich can enable oil refiners to dramatically reduce costs by developing residuesources for manufacture of its MSAR(R) fuel. The benefit of MSAR(R) manufacture for refiners is the release of valuablecutter stock into the distillate pool which significantly improves refiningprofit margins. The potential to run heavier and cheaper crudes is particularlysignificant to refiners. A saving of $5 per barrel on crude costs translates toa reduced operating cost of over $300 million per annum for a 200,000 barrel perday refinery. Quadrise acts as a sink and purchases the increased residue volumes arising fromheavier crudes, solving a major disposal problem for the refiner. MSAR(R)'sprice competitiveness has meant that Quadrise can place the residues at powerplants that are equipped with the necessary flue gas abatement equipment. Notonly does Quadrise eliminate the refiners disposal problems arising from lowvalue residue, but the usual sulphur emissions associated with these materialsare processed in custom built facilities in an environmentally acceptablemanner. Dr. Ian Duckels, a consultant to Quadrise and former Chairman of Nerefco, the BP/Texaco Joint Venture refinery in Rotterdam, and currently a specialist lecturerin refinery economics for the Petroleum Economist said: "For certain refinerieswith suitable configurations and the ability to supply appropriate powergeneration facilities, an MSAR(R) solution is the low-cost, margin-enhancing,easy-to-implement and efficient option, particularly when compared to other moreconventional high-capital cost upgrading processes. Processing residue to MSAR(R) avoids production of the significant additional quantities of greenhouse gason the refinery site associated with conventional upgrading technologies." Bill Howe, CEO, Quadrise Fuels International, said: "In addition to itsapplication in the downstream refining industry, the relevance of MSAR(R)'s rolefor oil field power generation and simultaneous enhancement of oil recoverythrough injection of carbon dioxide into hydrocarbon reservoirs has becomeobvious. The International Energy Agency have announced that the worlds supplyof oil will be even tighter in five years time and this technology has a placein extending reserves and crude output in the timeframe." For further information, please contact: Quadrise Fuels International plcBill Howe, CEOT: +44 (0)20 7550 4930 Smith & Williamson Corporate Finance LimitedAzhic Basirov / Siobhan Sergeant+44 (0)20 7131 4000 Parkgreen CommunicationsSimon Robinson / Clare Irvine+44 (0)20 7851 7480 Notes to editors: Quadrise Fuels International plc ("Quadrise") produces an emulsion fuel as a lowcost substitute for conventional heavy fuel oil ("HFO") for use in powergeneration plants and large steam raising or energy consuming industries. In manufacturing its fuels, Quadrise uses the least valuable elements of the oilbarrel, thus providing a very cost effective product whilst simultaneouslyfacilitating a means to market for the least desirable heavy crudes and refineryderived residues. The emulsion fuel product, termed MSAR(R) (Multiphase Superfine AtomisedResidue), has superior combustion characteristics to conventional HFO and coal,and has comparable or superior environmental performance in respect ofgreenhouse emissions. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Aug 20154:35 pmRNSPrice Monitoring Extension
29th Jul 20154:40 pmRNSSecond Price Monitoring Extn
29th Jul 20154:35 pmRNSPrice Monitoring Extension
21st Jul 20154:35 pmRNSPrice Monitoring Extension
25th Jun 20154:40 pmRNSSecond Price Monitoring Extn
25th Jun 20154:35 pmRNSPrice Monitoring Extension
5th Jun 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20151:52 pmRNSHolding(s) in Company
30th Mar 20157:00 amRNSHalf Yearly Report
20th Mar 20154:41 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Feb 20157:00 amRNSNotice of Interim Results and Business Update
13th Feb 201510:55 amRNSStmnt re Share Price Movement
9th Feb 20154:13 pmRNSHolding(s) in Company
30th Jan 201511:40 amRNSDirector's Dealing and Issue of Equity
19th Jan 20154:35 pmRNSPrice Monitoring Extension
16th Jan 20154:40 pmRNSSecond Price Monitoring Extn
16th Jan 20154:35 pmRNSPrice Monitoring Extension
12th Jan 20154:40 pmRNSSecond Price Monitoring Extn
12th Jan 20154:35 pmRNSPrice Monitoring Extension
7th Jan 20157:00 amRNSPersonnel Update
18th Dec 20147:00 amRNSProgramme Update and Purchase of MSAR MMUs
3rd Dec 20142:00 pmRNSHolding(s) in Company
3rd Dec 201411:15 amRNSDirector/PDMR Shareholding
3rd Dec 201410:45 amRNSHolding(s) in Company
28th Nov 20143:50 pmRNSResult of AGM
10th Nov 20147:00 amRNSCo-operation and Exclusive Supply Agreement
31st Oct 20147:00 amRNSTotal Voting Rights
22nd Oct 20143:12 pmRNSAcquisition of Minority Interest, Issue of Equity
20th Oct 20147:00 amRNSFinal Results
10th Oct 20142:33 pmRNSAppointment of Executive Director
8th Oct 201412:34 pmRNSDirectorate Change
11th Sep 20147:00 amRNSHolding(s) in Company
9th Jul 201412:20 pmRNSHolding(s) in Company
3rd Jul 20147:22 amRNSHalf Year Update on Active Programmes
30th May 20147:00 amRNSTotal Voting Rights
9th May 20142:45 pmRNSDirector/PDMR Shareholding
7th May 20142:25 pmRNSIssue of Equity
30th Apr 20147:00 amRNSTotal Voting Rights
17th Apr 20143:41 pmRNSChange of Shareholding
15th Apr 20144:40 pmRNSSecond Price Monitoring Extn
15th Apr 20144:35 pmRNSPrice Monitoring Extension
8th Apr 20144:35 pmRNSPrice Monitoring Extension
2nd Apr 20142:04 pmRNSIssue of Options and Director's Dealing
31st Mar 20147:00 amRNSTotal Voting Rights
25th Mar 201410:27 amRNSDirector/PDMR Shareholding
24th Mar 20147:00 amRNSHalf Yearly Report
6th Mar 20147:00 amRNSIssue of Equity
24th Feb 20147:00 amRNSRoyalty Agreement
24th Feb 20147:00 amRNSUpdate on active programmes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.